BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31108549)

  • 81. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy.
    Schenke-Layland K; Xie J; Magnusson M; Angelis E; Li X; Wu K; Reinhardt DP; Maclellan WR; Hamm-Alvarez SF
    Exp Eye Res; 2010 Feb; 90(2):223-37. PubMed ID: 19852957
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjögren's syndrome model mice.
    Nishiyama T; Mishima K; Obara K; Inoue H; Doi T; Kondo S; Saka M; Tabunoki Y; Hattori Y; Kodama T; Tsubota K; Saito I
    Clin Exp Immunol; 2007 Sep; 149(3):586-95. PubMed ID: 17614971
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Temporal gene expression analysis of Sjögren's syndrome in C57BL/6.NOD-Aec1Aec2 mice based on microarray time-series data using an improved empirical Bayes approach.
    Wang D; Xue L; Yang Y; Hu J; Li G; Piao X
    Mol Biol Rep; 2014 Sep; 41(9):5953-60. PubMed ID: 24990690
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burns WH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impaired neurotransmission in lacrimal and salivary glands of a murine model of Sjögren's syndrome.
    Zoukhri D; Kublin CL
    Adv Exp Med Biol; 2002; 506(Pt B):1023-8. PubMed ID: 12614026
    [No Abstract]   [Full Text] [Related]  

  • 86. ENaC in the Rabbit Lacrimal Gland and its Changes During Sjögren Syndrome and Pregnancy.
    Wang M; Huang J; Lu M; Zhang S; Ding C
    Eye Contact Lens; 2015 Sep; 41(5):297-303. PubMed ID: 25828511
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
    Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
    Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Expression of transcripts for cysteine-rich secretory proteins (CRISPs) in the murine lacrimal gland.
    Haendler B; Toda I; Sullivan DA; Schleuning WD
    J Cell Physiol; 1999 Mar; 178(3):371-8. PubMed ID: 9989783
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Murine models of Sjögren's syndrome.
    Jabs DA; Prendergast RA
    Adv Exp Med Biol; 1994; 350():623-30. PubMed ID: 8030545
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
    Hayashi Y; Haneji N; Hamano H
    Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Influence of sex on gene expression in the mouse lacrimal gland.
    Richards SM; Jensen RV; Liu M; Sullivan BD; Lombardi MJ; Rowley P; Schirra F; Treister NS; Suzuki T; Steagall RJ; Yamagami H; Sullivan DA
    Exp Eye Res; 2006 Jan; 82(1):13-23. PubMed ID: 15979613
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye.
    Sullivan DA; Sullivan BD; Evans JE; Schirra F; Yamagami H; Liu M; Richards SM; Suzuki T; Schaumberg DA; Sullivan RM; Dana MR
    Ann N Y Acad Sci; 2002 Jun; 966():211-22. PubMed ID: 12114274
    [TBL] [Abstract][Full Text] [Related]  

  • 93. c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion.
    Zoukhri D; Macari E; Choi SH; Kublin CL
    J Neurochem; 2006 Jan; 96(1):126-35. PubMed ID: 16300639
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model.
    Kiripolsky J; McCabe LG; Gaile DP; Kramer JM
    J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.
    Zhou J; Jin JO; Du J; Yu Q
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Use of topical cyclosporin A in a primary Sjögren's syndrome mouse model.
    Tsubota K; Saito I; Ishimaru N; Hayashi Y
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1551-9. PubMed ID: 9699544
    [TBL] [Abstract][Full Text] [Related]  

  • 97. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid.
    Takahashi M; Ishimaru N; Yanagi K; Haneji N; Saito I; Hayashi Y
    Clin Exp Immunol; 1997 Sep; 109(3):555-61. PubMed ID: 9328136
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Androgen control of gene expression in the mouse meibomian gland.
    Schirra F; Suzuki T; Richards SM; Jensen RV; Liu M; Lombardi MJ; Rowley P; Treister NS; Sullivan DA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3666-75. PubMed ID: 16186348
    [TBL] [Abstract][Full Text] [Related]  

  • 99. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
    Nguyen CQ; Gao JH; Kim H; Saban DR; Cornelius JG; Peck AB
    J Immunol; 2007 Jul; 179(1):382-90. PubMed ID: 17579059
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Apoptosis and related gene expression in lacrimal gland of cases with Sjögren's syndrome].
    Wu J; Fei P; Gong Y; Zhao J; Dong J; Tang F
    Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):255-8, 14. PubMed ID: 11853607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.